MAPT and Alzheimer disease: The first increasing and then falling trend of sUA levels could be due to the early compensatory antioxidative function for Aβ42 and the later decompensation and self-exhaustion for anti-Aβ42 and the Aβ-tau pathological process or other amplifying vicious cascade in the later stage of AD.